1. Hoechst Aktiengesellschaft (16 from 6,662 patents)

2. Aventis Pharma Deutschland, Gmbh (5 from 330 patents)

3. Sanofi-a Ventis Deutschland Gmbh (3 from 1,830 patents)

1. 8088799 - Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor

2. 7601863 - Use of PPAR agonists for the treatment of congestive heart failure

3. 7514423 - Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases

4. 6930103 - Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases

5. 6844361 - Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor

6. 6602866 - Mercaptoacetylamide derivatives, a process for their preparation and their use

7. 6462024 - Use of inhibitors of the sodium-hydrogen exchanger for the production of a medicament for decreasing undesired effects of substrates of the heart

8. 6420430 - Use of inhibitors of the sodium-hydrogen exchanger for preparing a medicament for preventing age-related disorders, and for prolonging life

9. 6335467 - Substituted benzenesulfonylureas and thioureas-process for their preparation and their use as pharmaceuticals

10. 6090981 - Substituted benzenesulfonylureas and -thioureas--process for their

11. 5849755 - 3-amidochromanylsulfonyl(thio)ureas, processes for their preparation,

12. 5811448 - Substituted chromanysulfonyl (thio) ureas, processing for their

13. 5776980 - Substituted benzenesulfonylureas and -thioureas-process for their

14. 5698596 - Substituted benzenesulfonylureas and thioureas process for their

15. 5574069 - Substituted benzenesulfonylureas and -thioureas- process for their